NSEGeneral Updates8 Sept 2026 · 8 Sept 2026, 06:45 pm

General Updates

Viyash Scientific Limited · VIYASH

✦ AI SummaryM&A

Viyash Scientific Limited has received regulatory approval for the acquisition of 100% shareholding in BioForLife Italia S.r.l. and expects to complete the transaction within two months.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Update on proposed acquisition of BioForLife Italia S.r.l

Attachments (1)

📄

SEQUENT1_08092026184504_SE_Intimation.pdf

pdf

Download →
View document text
Viyash Scientific Limited (Formerly known as Sequent Scientific Limited) Registered Office: 3rd Floor, Srivalli’s Corporate, Plot No.290, Road No.6, Sy.No.33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India-500033 T: +91 40 23635000 E: investorrelations@viyash.com Website: www.viyash.com CIN: L99999TS1985PLC196357 September 08, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip code: 512529 Symbol: VIYASH Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Update on proposed acquisition of BioForLife Italia S.r.l Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, and in continuation of our earlier disclosures dated June 8, 2026 and July 21, 2026 (collectively referred to as the “Disclosures”) regarding the proposed acquisition of 100% shareholding in BioForLife Italia S.r.l., Milan, Italy by Alivira Animal Health Limited, Ireland, a step-down wholly owned subsidiary of Viyash Scientific Limited, we wish to inform you that the requisite approval in connection with the applicable Italian FDI / Golden Power regulations has been received from the relevant Italian authorities. Further, taking into account the remaining customary closing formalities and closing conditions, the expected timeline for completion of the transaction has been revised, and the transaction is now expected to be completed within two months from the date of this intimation. Except for the receipt of the aforesaid regulatory approval and the revised timeline for completion of the transaction, all other material terms and conditions set out in the Disclosures remain unchanged. We request you to take the same on record. Yours faithfully, For Viyash Scientific Limited (Formerly known as Sequent Scientific Limited) Yoshita Vora Company Secretary & Compliance Officer